B-cell immunosuppressants (Novartis)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameB-cell immunosuppressants (Novartis)
Drug Alias Nameantibody production inhibitors (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionB cells modulatorsImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A